Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos

Michel Ducreux, Head of the GI Service at Institut Gustave Roussy, talks about the new evidence and its clinical implications, as reported in his Phase II study at the ESMO World Congress on Gastrointestinal Cancer.

Episode metadata supplied by the publisher feed · Published Jul 16, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos

0:00 6:23

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Times - OncTimes Talk?

This episode is 6 minutes long.

When was this Oncology Times - OncTimes Talk episode published?

This episode was published on July 16, 2026.

Can I download this Oncology Times - OncTimes Talk episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!